Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human GCNT3 Antikörper:
anti-Mouse (Murine) GCNT3 Antikörper:
anti-Rat (Rattus) GCNT3 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal GCNT3 Primary Antibody für IHC - ABIN966193
Yeh, Ong, Fukuda: Molecular cloning and expression of a novel beta-1, 6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches. in The Journal of biological chemistry 1999
Show all 3 Pubmed References
Human Polyclonal GCNT3 Primary Antibody für IHC - ABIN966194
Schwientek, Nomoto, Levery, Merkx, van Kessel, Bennett, Hollingsworth, Clausen: Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel beta1,6-N-acetylglucosaminyltransferase forming core 2 and core 4. in The Journal of biological chemistry 1999
Show all 3 Pubmed References
Dog (Canine) Polyclonal GCNT3 Primary Antibody für ELISA, WB - ABIN548192
Schwientek, Yeh, Levery, Keck, Merkx, van Kessel, Fukuda, Clausen: Control of O-glycan branch formation. Molecular cloning and characterization of a novel thymus-associated core 2 beta1, 6-n-acetylglucosaminyltransferase. in The Journal of biological chemistry 2000
Human Polyclonal GCNT3 Primary Antibody für ELISA, WB - ABIN238636
Petrosyan, Ali, Verma, Cheng, Cheng: Non-muscle myosin IIA transports a Golgi glycosyltransferase to the endoplasmic reticulum by binding to its cytoplasmic tail. in The international journal of biochemistry & cell biology 2012
Show all 2 Pubmed References
Human Polyclonal GCNT3 Primary Antibody für ICC, IF - ABIN4313775
van der Post, Hansson: Membrane protein profiling of human colon reveals distinct regional differences. in Molecular & cellular proteomics : MCP 2014
High GCNT3 expression is associated with metastatic melanomas.
GCNT3 was regarded as an oncogene in non-small cell lung cancer, and a target of miR-302b-3p, which regulated cell proliferation, migration and invasion in a GCNT3-dependent manner and E-cadherin, N-cadherin, vimentin, cyclin D1 and p-Erk appeared to be downstream molecules of the miR-302b-3p/GCNT3 pathway.
In this Molecular Pathways article, we briefly discuss the potential role of mucin synthesis in cancers, ways to improve drug delivery and disrupt mucin mesh to overcome chemoresistance by targeting mucin synthesis, and the unique opportunity to target the GCNT3 pathway for the prevention and treatment of cancers.
This study provides the concepts toward the design of carbohydrate-dependent inhibition of EPEC and EHEC O157:H7 adhesion to human intestinal epithelial cells.
In HeLa cells transiently expressing C2GnT-M-GFP, knockdown of KRT1 does not affect Golgi morphology but leaves C2GnT-M outside of the Golgi, resulting in the formation of sialyl-T antigen.
low GCNT3 expression is a promising prognostic biomarker for colon cancer that could be used to identify early-stage colon cancer patients at high risk of relapse.
Golgi fragmentation is accompanied by the increased association of NMIIA with C2GnT-M and its degradation by proteasomes.
Data show that the Golgi docking of vesicular complexes (VCs) use different golgins for docking: C2GnT-M-carrying VC (C2GnT-M-VC) utilizes Giantin, whereas C1GalT1-VC employs GM130-GRASP65 complex.
C2GnT2 KO mice have decreased mucosal barrier function in the digestive tract, reduced levels of circulating IgGs and fecal IgA, and increased susceptibility to experimental colitis
EGF suppressed C2GnT activity in a time- and dose-dependent fashion, and also suppressed core 4 beta1,6 N-acetylglucosaminyltransferase (C4GnT) activity
Frequently downregulated in colorectal cancer and suppresses colon cancer cell growth.
Results describe the identification of the cis-regulatory elements of human C2GnT-M gene.
Results report the cloning of four different bovine core 2 beta6 N-acetylglucosaminyltransferase transcripts that are different only at 5'-untranslated regions.
This gene encodes a member of the N-acetylglucosaminyltransferase family. The encoded protein is a beta-6-N-acetylglucosamine-transferase that catalyzes the formation of core 2 and core 4 O-glycans on mucin-type glycoproteins.
glucosaminyl (N-acetyl) transferase 3, mucin type
, glucosaminyl transferase 3, mucin type
, beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3-like
, C2GnT-mucin type
, beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3
, core 2/core 4 beta-1,6-N-acetylglucosaminyltransferase
, mucus-type core 2 beta-1,6-N-acetylglucosaminyltransferase
, core 2 beta-1,6-N-acetylglucosaminyltransferase II